Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 24% year on year to $164.3 million. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback